Yahoo Poland Wyszukiwanie w Internecie

Zaloguj się

Search results

  1. www.ahajournals.org › doi › 10Management of Patients at Risk for and With Left Ventricular...

    15 wrz 2022 · Complete thrombus resolution was achieved in 62.3% (n=99) at a median of 103 days (interquartile range, 32–392 days). 17 Recurrence of thrombus or an increase in LV thrombus area was observed in 14.5% (n=23), a finding associated with poor adherence, prothrombotic conditions, and increased mortality. 17.

    • View EPUB

      (r·=™Z¢ÔþÛôn =Yj > h~}¤ÄŽ@ ]|Ÿög š×/|ë@¾l÷ †u¢ÚsÅCÈù?\yÓ©b...

    • Linda S. Williams

      HRs for stroke recurrence ranged from 1.68 (95% CI,...

    • PDF/Epub

      PK u!3Yoa«, mimetypeapplication/epub+zipPK u!3Y...

    • Trial

      Background—The Randomized Evaluation of Long-term...

  2. www.ahajournals.org › doi › 10Clinical Outcome After Left Ventricular Thrombus Resolution: Who...

    17 kwi 2023 · However, in 115 patients with treated LV thrombus and who had documented resolution on repeat echocardiography, about 1 in 4 patients had recurrent LVT at a median follow‐up of 1.2 years, and about 1 in 5 patients with LVT recurrence experienced MACE.

  3. www.jacc.org › doi › 10Left Ventricular Thrombus: Contemporary Etiologies, Treatment ...

    Over 1-year follow-up, 13% died (none due to bleeding), 1.9% experienced embolic events (all strokes), and 2.8%, nonfatal bleeding. Among those with follow-up imaging within 1 year (64.8%), thrombus resolution occurred in 75% who received warfarin, 40% who received LMWH, and 100% who received DOACs.

  4. academic.oup.com › ehjcimaging › advance-article-abstractEvolution of Left Ventricular Thrombus on Serial Cardiovascular...

    22 paź 2024 · Data on LV thrombus evolution and the associated embolic risk are scarce. We aimed to describe the evolution of LV thrombus on serial cardiovascular magnetic resonance imaging (CMR) – the current reference standard for the detection of LV thrombus, and identify correlates of no resolution and the embolic risk associated with resolution status.

  5. pubmed.ncbi.nlm.nih.gov › 36106537Management of Patients at Risk for and With Left Ventricular...

    15 wrz 2022 · Therefore, this American Heart Association scientific statement was commissioned with the goals of addressing 8 key clinical management questions related to LV thrombus, including the prevention and treatment after myocardial infarction, prevention and treatment in dilated cardiomyopathy, management of mural (laminated) thrombus, imaging of LV t...

  6. pubmed.ncbi.nlm.nih.gov › 36951736An evidence-based evaluation of left ventricular thrombus...

    1 cze 2023 · Pooled results from six studies that evaluated resolution at 6 months suggest that 80% of LVT were resolved. Apixaban was associated with the highest rate of (93.3%) whereas warfarin exhibited the lowest rate of resolution 73.1%. LVT is best managed with DOAC compared to warfarin therapy.

  7. www.jacc.org › doi › 10CONTEMPORARY ETIOLOGIES, TREATMENT STRATEGIES, AND OUTCOMES OF...

    Left ventricular (LV) thrombus is a feared complication of LV dysfunction associated with high rates of systemic embolism. However, contemporary data are lacking. Methods. We identified patients diagnosed with LV thrombus on echocardiography (±contrast) at Brigham and Women's Hospital between January 2008 and May 2015. Results.